For Bahraini pharmaceutical companies aiming to export products to India, obtaining approval from the Central Drugs Standard Control Organisation (CDSCO) is mandatory. The registration process involves several key steps:
1. Application Submission: Companies must register on the CDSCO's SUGAM portal, providing detailed information about the applicant and the products intended for import.
2. Document Submission: Essential documents include the Certificate of Pharmaceutical Product (COPP), Good Manufacturing Practice (GMP) certificate, and a free sale certificate from the country of origin.
3. Product Approval: CDSCO evaluates the safety, efficacy, and quality of the pharmaceutical products. This may involve site inspections and assessments of manufacturing processes.
4. Import License Issuance: Upon successful evaluation, CDSCO grants an import license, authorizing the company to import and distribute the pharmaceutical products in India.
The entire process can take several months, depending on the complexity of the products and the completeness of the submitted documentation.